Marc Bourlière Selected Research

Marc Bourlière Research Topics

Disease

39	Infections 02/2024 - 05/2002
31	Chronic Hepatitis C 01/2023 - 05/2002
31	Fibrosis (Cirrhosis) 10/2022 - 12/2006
14	Hepatitis C 02/2024 - 10/2006
12	Liver Cirrhosis (Hepatic Cirrhosis) 06/2024 - 07/2005
12	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 08/2007
10	Neoplasms (Cancer) 01/2023 - 04/2016
8	Liver Diseases (Liver Disease) 10/2022 - 12/2006
5	Chronic Hepatitis B 02/2022 - 10/2006
4	Liver Neoplasms (Liver Cancer) 08/2020 - 04/2016
4	Anemia 01/2016 - 04/2009
3	Portal Hypertension 05/2024 - 04/2015
3	Autoimmune Hepatitis 01/2022 - 04/2006
3	Coinfection 01/2019 - 01/2006
3	Neutropenia 01/2018 - 01/2013
2	Hepatitis B 06/2024 - 12/2008
2	Viremia 06/2024 - 01/2018
2	Hypertension (High Blood Pressure) 02/2022 - 01/2018
2	Chronic Renal Insufficiency 01/2022 - 01/2018
2	Disease Progression 01/2021 - 11/2019
2	Inflammation (Inflammations) 04/2015 - 12/2006
2	Virus Diseases (Viral Diseases) 02/2015 - 02/2006
2	Pruritus (Itching) 02/2012 - 04/2009
2	Exanthema (Rash) 02/2012 - 04/2009
2	Chronic Hepatitis (Chronic Active Hepatitis) 08/2007 - 04/2006
1	Hepatitis D 06/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Ascites 10/2022
1	Dyslipidemias (Dyslipidemia) 02/2022
1	Cholestasis 01/2022
1	End Stage Liver Disease 01/2022
1	Cholangitis 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Focal Nodular Hyperplasia 01/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2022
1	Iron Overload 01/2022
1	HIV Infections (HIV Infection) 11/2021
1	Esophageal and Gastric Varices (Esophageal Varices) 01/2019
1	Thrombocytopenia 4 01/2018
1	Leukopenia 01/2018
1	Diabetes Mellitus 01/2018

Drug/Important Bio-Agent (IBA)

34	Ribavirin (Virazole)FDA LinkGeneric 01/2017 - 05/2002
32	Antiviral Agents (Antivirals)IBA 02/2024 - 02/2006
24	InterferonsIBA 11/2018 - 05/2002
11	RNA (Ribonucleic Acid)IBA 06/2024 - 01/2006
10	Protease Inhibitors (Protease Inhibitor)IBA 01/2017 - 06/2011
9	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 03/2016 - 02/2012
9	telaprevirIBA 01/2016 - 04/2009
7	SofosbuvirIBA 01/2022 - 01/2015
7	faldaprevirIBA 05/2016 - 06/2011
5	daclatasvirIBA 01/2018 - 02/2014
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 06/2024 - 01/2017
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 08/2020 - 06/2017
4	peginterferon alfa-2a (Pegasys)FDA Link 01/2017 - 10/2006
4	deleobuvirIBA 02/2015 - 08/2013
3	Coffee FDA Link 06/2022 - 01/2019
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 02/2012
3	ledipasvirIBA 01/2017 - 01/2015
3	sofosbuvir drug combination ledipasvirIBA 01/2017 - 04/2015
3	peginterferon alfa-2b (Pegintron)FDA Link 01/2013 - 02/2007
2	Transaminases (Aminotransferases)IBA 06/2024 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2017
2	AutoantibodiesIBA 01/2022 - 01/2022
2	BilirubinIBA 08/2020 - 01/2018
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2019 - 01/2009
2	TabletsIBA 01/2018 - 01/2015
2	elbasvirIBA 01/2018 - 01/2017
2	grazoprevirIBA 01/2018 - 01/2017
2	sofosbuvir velpatasvir voxilaprevir drug combinationIBA 01/2018 - 01/2017
2	velpatasvirIBA 01/2017 - 12/2015
2	AntigensIBA 01/2017 - 12/2006
2	Hemoglobins (Hemoglobin)IBA 01/2017 - 01/2013
2	N- (8- aminohexyl)- 5- iodonaphthalene- 1- sulfonamide (W8)IBA 03/2016 - 01/2016
2	Inosine TriphosphataseIBA 01/2016 - 01/2015
2	NucleosidesIBA 01/2015 - 02/2014
2	asunaprevirIBA 02/2014 - 01/2013
2	InterleukinsIBA 02/2014 - 01/2012
2	Erythropoietin FDA Link 09/2013 - 08/2007
2	Biomarkers (Surrogate Marker)IBA 03/2007 - 07/2005
1	hemoglobin DIBA 06/2024
1	CannabinoidsIBA 10/2022
1	4-(3-chlorophenylsulfanyl)piperidineIBA 10/2022
1	Ferritins (Ferritin)IBA 01/2022
1	Contrast MediaIBA 01/2022
1	AlbuminsIBA 08/2020
1	Ethiodized Oil (Ethiodol)FDA Link 11/2019
1	Sorafenib (BAY 43-9006)FDA Link 11/2019
1	glecaprevir and pibrentasvirIBA 01/2018
1	omega-Chloroacetophenone (Mace)IBA 01/2018
1	Serum AlbuminIBA 01/2018
1	glecaprevirIBA 01/2018
1	pibrentasvirIBA 01/2018

Therapy/Procedure

33	Therapeutics 02/2024 - 05/2002
4	Retreatment 01/2018 - 04/2007
3	Liver Transplantation 10/2022 - 01/2021
3	Duration of Therapy 11/2019 - 05/2002
2	Transplantation 01/2020 - 01/2018
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 05/2024
1	Transjugular Intrahepatic Portasystemic Shunt 05/2024
1	Renal Dialysis (Hemodialysis) 01/2018